Chemical Nature and Reaction Mechanisms of the Molybdenum Cofactor of Xanthine Oxidoreductase

Overview

Journal Curr Pharm Des

Publisher Bentham Science Publishers

Date 2012 Nov 3

PMID 23116398

Citations 30

Authors

Ken Okamoto

Teruo Kusano

Takeshi Nishino

Affiliations

Soon will be listed here.

Abstract

Xanthine oxidoreductase (XOR), a complex flavoprotein, catalyzes the metabolic reactions leading from hypoxanthine to xanthine and from xanthine to urate, and both reactions take place at the molybdenum cofactor. The enzyme is a target of drugs for therapy of gout or hyperuricemia. We review the chemical nature and reaction mechanisms of the molybdenum cofactor of XOR, focusing on molybdenum-dependent reactions of actual or potential medical importance, including nitric oxide (NO) synthesis. It is now generally accepted that XOR transfers the water-exchangeable -OH ligand of the molybdenum atom to the substrate. The hydroxyl group at OH-Mo(IV) can be replaced by urate, oxipurinol and FYX-051 derivatives and the structures of these complexes have been determined by xray crystallography under anaerobic conditions. Although formation of NO from nitrite or formation of xanthine from urate by XOR ischemically feasible, it is not yet clear whether these reactions have any physiological significance since the reactions are catalyzed at a slow rate even under anaerobic conditions.

Citing Articles

PRPS activity tunes redox homeostasis in Myc-driven lymphoma.

MacMillan A, Karki B, Yang J, Gertz K, Zumwalde S, Patel J bioRxiv. 2025; .

PMID: 39868212 PMC: 11761749. DOI: 10.1101/2025.01.08.632009.

Computational Insights into the Radical Scavenging Activity and Xanthine Oxidase Inhibition of the Five Anthocyanins Derived from Grape Skin.

Lu X, Li J, Wang B, Qin S Antioxidants (Basel). 2024; 13(9).

PMID: 39334776 PMC: 11428504. DOI: 10.3390/antiox13091117.

Molybdenum's Role as an Essential Element in Enzymes Catabolizing Redox Reactions: A Review.

Adamus J, Ruszczynska A, Wyczalkowska-Tomasik A Biomolecules. 2024; 14(7).

PMID: 39062583 PMC: 11275037. DOI: 10.3390/biom14070869.

Reactive Oxygen Species and Strategies for Antioxidant Intervention in Acute Respiratory Distress Syndrome.

Lim E, Lee S, Shin H, Kim G Antioxidants (Basel). 2023; 12(11).

PMID: 38001869 PMC: 10669909. DOI: 10.3390/antiox12112016.

Does the Micronutrient Molybdenum Have a Role in Gestational Complications and Placental Health?.

Foteva V, Fisher J, Qiao Y, Smith R Nutrients. 2023; 15(15).

PMID: 37571285 PMC: 10421405. DOI: 10.3390/nu15153348.

References

Okamoto K, Matsumoto K, Hille R, Eger B, Pai E, Nishino T . The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition. Proc Natl Acad Sci U S A. 2004; 101(21):7931-6. PMC: 419534. DOI: 10.1073/pnas.0400973101. View

Yamaguchi Y, Matsumura T, Ichida K, Okamoto K, Nishino T . Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: roles of active site residues in binding and activation of purine substrate. J Biochem. 2007; 141(4):513-24. DOI: 10.1093/jb/mvm053. View

Porras A, Palmer G . The room temperature potentiometry of xanthine oxidase. pH-dependent redox behavior of the flavin, molybdenum, and iron-sulfur centers. J Biol Chem. 1982; 257(19):11617-26. View

ELION G, Kovensky A, HITCHINGS G . Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem Pharmacol. 1966; 15(7):863-80. DOI: 10.1016/0006-2952(66)90163-8. View

Xia M, Dempski R, Hille R . The reductive half-reaction of xanthine oxidase. Reaction with aldehyde substrates and identification of the catalytically labile oxygen. J Biol Chem. 1999; 274(6):3323-30. DOI: 10.1074/jbc.274.6.3323. View

Spector T, Johns D . Oxidation of 4-hydroxypyrazolo (3,4-d) pyrimidine by xanthine oxidase, the route of electron transfer from substrate to acceptor dyes. Biochem Biophys Res Commun. 1968; 32(6):1039-44. DOI: 10.1016/0006-291x(68)90134-4. View

Harrison R . Structure and function of xanthine oxidoreductase: where are we now?. Free Radic Biol Med. 2002; 33(6):774-97. DOI: 10.1016/s0891-5849(02)00956-5. View

Maia L, Moura J . Nitrite reduction by xanthine oxidase family enzymes: a new class of nitrite reductases. J Biol Inorg Chem. 2010; 16(3):443-60. DOI: 10.1007/s00775-010-0741-z. View

Truglio J, Theis K, Leimkuhler S, Rappa R, Rajagopalan K, Kisker C . Crystal structures of the active and alloxanthine-inhibited forms of xanthine dehydrogenase from Rhodobacter capsulatus. Structure. 2002; 10(1):115-25. DOI: 10.1016/s0969-2126(01)00697-9. View

10.

Hunt J, MASSEY V, Dunham W, SANDS R . Redox potentials of milk xanthine dehydrogenase. Room temperature measurement of the FAD and 2Fe/2S center potentials. J Biol Chem. 1993; 268(25):18685-91. View

11.

Saito T, Nishino T . Differences in redox and kinetic properties between NAD-dependent and O2-dependent types of rat liver xanthine dehydrogenase. J Biol Chem. 1989; 264(17):10015-22. View

12.

Olson J, Ballou D, Palmer G, MASSEY V . The mechanism of action of xanthine oxidase. J Biol Chem. 1974; 249(14):4363-82. View

13.

Berry C, Hare J . Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol. 2003; 555(Pt 3):589-606. PMC: 1664875. DOI: 10.1113/jphysiol.2003.055913. View

14.

Rajagopalan K, Johnson J . The pterin molybdenum cofactors. J Biol Chem. 1992; 267(15):10199-202. View

15.

Nossaman V, Nossaman B, Kadowitz P . Nitrates and nitrites in the treatment of ischemic cardiac disease. Cardiol Rev. 2010; 18(4):190-7. PMC: 2885014. DOI: 10.1097/CRD.0b013e3181c8e14a. View

16.

Iwasaki T, Okamoto K, Nishino T, Mizushima J, Hori H . Sequence motif-specific assignment of two [2Fe-2S] clusters in rat xanthine oxidoreductase studied by site-directed mutagenesis. J Biochem. 2000; 127(5):771-8. DOI: 10.1093/oxfordjournals.jbchem.a022669. View

17.

Hille R, Nishino T, Bittner F . Molybdenum enzymes in higher organisms. Coord Chem Rev. 2011; 255(9-10):1179-1205. PMC: 3079273. DOI: 10.1016/j.ccr.2010.11.034. View

18.

ENROTH C, Eger B, Okamoto K, Nishino T, Pai E . Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proc Natl Acad Sci U S A. 2000; 97(20):10723-8. PMC: 27090. DOI: 10.1073/pnas.97.20.10723. View

19.

Nishino T, Schopfer L, MASSEY V . The reactivity of chicken liver xanthine dehydrogenase with molecular oxygen. J Biol Chem. 1989; 264(5):2518-27. View

20.

Cao H, Pauff J, Hille R . Substrate orientation and catalytic specificity in the action of xanthine oxidase: the sequential hydroxylation of hypoxanthine to uric acid. J Biol Chem. 2010; 285(36):28044-53. PMC: 2934669. DOI: 10.1074/jbc.M110.128561. View